The American Society of Addiction Medicine has released the first clinical guide and national resource for managing the intoxication and withdrawal of medetomidine.
|Videos|January 24, 2022
The Opioid Epidemic Is Alive—And Unwell
Author(s)John J. Miller, MD
This is the sad reality: In the first year of COVID-19, there were 20,000 more opioid overdose deaths than years previous.
Advertisement
John J. Miller, MD, shares concern and information about the alarming opioid overdose epidemic in America. The numbers of overdose deaths in 2021 is expected to spike above 100,000.
Dr Miller is medical director, Brain Health, Exeter, New Hampshire; Editor in Chief, Psychiatric TimesTM; staff psychiatrist, Seacoast Mental Health Center, Exeter; consulting psychiatrist, Exeter Hospital, Exeter; and consulting psychiatrist, Insight Meditation Society, Barre, Massachusetts.
Advertisement
Related to this article
New data shows cannabis dominates teens’ substance-related ER visits, often with alcohol or stimulants, urging better screening and intervention for psychosis, vomiting.
GLP-1 drugs enter psychiatry, curbing antipsychotic weight gain while raising new questions about addiction, mood, eating disorders, and culture.
Miss Golden Corner 2026 discusses the South Carolina campus naloxone law she helped start and her push to reduce addiction stigma in rural communities.
National survey shows most US adults don’t know AUD medications exist, and safety concerns plus racial disparities shape hesitation toward treatment.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Cannabis Use Prevalent In Substance-Related Adolescent Emergency Care: Insights From Kevin Xu, MD
2
Schizo-Obsessed! Untangling the Overlap Between Obsessive Compulsive Disorder and Schizophrenia
3
NDA Submission Complete: COMP360 Psilocybin for Treatment-Resistant Depression
4
Promoting Literacy to Improve Child Development: Reading Model Boosts Efforts
5